← Back to Search

E. Pre-surgery Standard Care + Augmentation Noom Bariatric for Obesity

N/A
Waitlist Available
Led By Tom Hildebrandt, PsyD
Research Sponsored by Noom Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 weeks, 3, 6, 9, and 12 months
Awards & highlights

Study Summary

This trial will test whether the Noom Coach for Bariatric Health platform can help improve standard interventions used in bariatric surgery programs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 weeks, 3, 6, 9, and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 8 weeks, 3, 6, 9, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Anthropometric changes (height)
Anthropometric changes (weight)
Change in adherence to dietary recommendations
+2 more
Secondary outcome measures
Depression Anxiety Stress Scales (DASS)
Eating Disorders
Short Form-36 Health Survey (SF-36)

Trial Design

8Treatment groups
Experimental Treatment
Active Control
Group I: G. Pre-surgery Standard Care + Augmentation Noom BariatricExperimental Treatment1 Intervention
The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care non-responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
Group II: E. Pre-surgery Standard Care + Augmentation Noom BariatricExperimental Treatment1 Intervention
The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
Group III: D. Presurgery Noom Bariatric + Augmentation Standard CareExperimental Treatment1 Intervention
Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention non-responsive individuals will be randomized post-surgery to "usual care" in which participants are free to seek any assistance for their bariatric post-surgery care during the study period.
Group IV: C. Presurgery Noom Bariatric + Augmentation Noom BariatricExperimental Treatment1 Intervention
Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention non-responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
Group V: B. Presurgery Noom Bariatric + Augmentation Standard CareExperimental Treatment1 Intervention
Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention responsive individuals will be randomized post-surgery to "usual care" in which participants are free to seek any assistance for their bariatric post-surgery care during the study period.
Group VI: A. Presurgery Noom Bariatric + Augmentation Noom BariatricExperimental Treatment1 Intervention
Self-monitoring will be conducted through Noom Coach for Bariatric Health, and individuals will receive a specialized set of instructions on how to use the app. Intervention responsive individuals will be randomized post-surgery to Noom Bariatric augmentation.
Group VII: F. Pre-surgery Standard Care + Augmentation Standard CareActive Control1 Intervention
The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care responsive individuals will be randomized post-surgery to usual care.
Group VIII: H. Pre-surgery Standard Care + Augmentation Standard CareActive Control1 Intervention
The control group will be a "usual care" condition in which participants are free to seek any assistance for their bariatric surgery care during the study period. Usual care non-responsive individuals will be randomized post-surgery to usual care.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Noom Coach for Bariatric Health
2018
N/A
~250

Find a Location

Who is running the clinical trial?

Noom Inc.Lead Sponsor
15 Previous Clinical Trials
2,261 Total Patients Enrolled
8 Trials studying Obesity
1,596 Patients Enrolled for Obesity
Icahn School of Medicine at Mount SinaiOTHER
857 Previous Clinical Trials
524,071 Total Patients Enrolled
16 Trials studying Obesity
16,197 Patients Enrolled for Obesity
Tom Hildebrandt, PsyDPrincipal InvestigatorIcahn School of Medicine at Mount Sinai
5 Previous Clinical Trials
481 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Noom Coach for Bariatric Health
2018. "Noom Coach for Bariatric Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03887078.
~30 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top